| Literature DB >> 26866493 |
Khashayar Dashtipour1, Farzin Pedouim1.
Abstract
Botulinum toxin (BoNT) formulations are being used for a variety of medical applications. The use of BoNT preparations is continuously expanding with new formulations and indications. Of the seven antigenically distinct BoNTs, only two serotypes, type A and type B are commonly available for therapeutic use. The four available BoNT products are not equivalent and the knowledge of their formulations is crucial for product selection, avoidance of medication errors, therapeutic efficacy and safety. Generally, BoNT injection is a safe procedure when administered by an experienced injector. Side effects are always transient, and in the majority of cases they are mild and tolerable. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Mesh:
Substances:
Year: 2016 PMID: 26866493 DOI: 10.1055/s-0035-1571213
Source DB: PubMed Journal: Semin Neurol ISSN: 0271-8235 Impact factor: 3.420